The AquaVENT® FD140i, our new and improved dual therapy flow driver, is now available to healthcare professionals and institutions in the Philippines through our distribution partner, Healthsolutions.
As hospitals in the Philippines continue to struggle with COVID-19, an ongoing issue is the need to maintain different care options so that patients can receive both high flow and CPAP treatments.
Transitioning from HFOT to CPAP can be costly and time consuming and even a few seconds without respiratory support can significantly reduce treatment success rate.
The AquaVENT® FD140i offers a complete solution by providing seamless transition between High Flow and CPAP within one compact device, significantly improving the quality of care.
As the device can be used in a wide range of hospital departments such as the ICU, emergency room, coronary care, post-op recovery and the HDU, this also reduces overall hospital costs. Along with the savings associated with purchasing a single device, the operational costs are also reduced.
Paul Murphy, Business Development Executive at Armstrong Medical said, ”We are excited to partner with Healthsolutions in the Philippines on the AquaVENT® FD140i. This device will allow medical staff to transition a patient efficiently between safe and effective CPAP therapy and High Flow Oxygen therapy. The versatile dual therapy device with specific modes for neonatal, paediatric and adult patients, benefits multiple acute care departments by helping to streamline the delivery of care.”
In addition to these benefits, the AquaVENT® FD140i comes with multiple innovative features that make it easier for healthcare professionals to manage their patients’ respiratory needs.
Related Articles
'BE INSPIRED’ WITH ARMSTRONG MEDICAL STUDY DAYS
BE INSPIRED TO BE® WITH ARMSTRONG MEDICAL
Armstrong Medical joins ABHI UK Pavilion showcasing strengths of UK HealthTech at MEDICA 2022.
It's the little things, Neonatal Nurse Meeting
